Cannabis Bioscience International Holdings, Inc.

OTCPK:CBIH Stock Report

Market Cap: US$7.4m

Cannabis Bioscience International Holdings Past Earnings Performance

Past criteria checks 0/6

Cannabis Bioscience International Holdings's earnings have been declining at an average annual rate of -9.3%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 44.3% per year.

Key information

-9.3%

Earnings growth rate

-2.6%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate44.3%
Return on equityn/a
Net Margin-153.8%
Last Earnings Update31 Aug 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Cannabis Bioscience International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CBIH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 240-110
31 May 240-110
29 Feb 240-110
30 Nov 230-110
31 Aug 230-110
31 May 230-110
28 Feb 230-110
30 Nov 220-110
31 Aug 220-110
31 May 220-110
28 Feb 220-110
31 May 211010
31 May 200-110

Quality Earnings: CBIH is currently unprofitable.

Growing Profit Margin: CBIH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CBIH is unprofitable, and losses have increased over the past 5 years at a rate of 9.3% per year.

Accelerating Growth: Unable to compare CBIH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CBIH is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).


Return on Equity

High ROE: CBIH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies